Indraprastha Medical Corporation Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) approved audited financial results for FY25 (year ended March 31, 2025) with a clean (unmodified) auditor opinion. Revenue from operations grew to Rs. 1,356.36 crore from Rs. 1,244.70 crore (~9% YoY), while profit after tax jumped to Rs. 160.99 crore from Rs. 123.96 crore (~30% YoY), driving EPS to Rs. 17.56 from Rs. 13.52. The Board recommended a dividend of Rs. 4.50 per share (45%), unchanged from last year. Operating cash flow stood at Rs. 156.75 crore, reserves strengthened to Rs. 505.01 crore, and the company confirmed it has no outstanding qualified borrowings, so it is not classified as a Large Corporate.
Strong profit growth (~30%) with margin expansion and maintained dividend signals healthy operational performance, likely to be viewed positively by shareholders. Declining operating cash flow despite higher profits (due to working capital changes) is a minor watch point.